Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: a Randomised, Controlled, Open-label, Blinded Endpoint Trial

NCT05539859 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT05539859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05539859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: a Randomised, Controlled, Open-label, Blinded Endpoint Trial
Lead sponsor
Southwest Hospital, China
Phase
Not applicable
Overall status
Recruiting
Start date
November 18, 2022
Completion date
September 1, 2026
Enrollment
560 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage basal ganglia